Obagi Nu-Derm Clear Fx skin brightening cream tube with blue and white Obagi branding
Promising for Hyperpigmentation
What Makes This Different

The 7% arbutin concentration is genuinely exceptional in the OTC market — most competing brightening products use 1-2% arbutin, if they use it at all. This high dosage, combined with the legacy of the Nu-Derm system's hydroquinone-based predecessor, positions Clear Fx as a serious brightening treatment rather than a cosmetic brightener.

Obagi

Obagi Nu-Derm Clear Fx Review

High-Dose Arbutin Brightener
treatment cream clinical Vegan Not Cruelty Free

A serious brightening treatment built around one of the highest OTC arbutin concentrations available. Slower than hydroquinone but gentler and safer for long-term use — if you have the patience for a 3-6 month timeline. The SLS and parabens in the formula feel outdated for the $125 asking price.

$125.00
2 fl oz / 57 g
4.2 ★★★★★
200 reviews
Made in United States Launched 2014 All-year use PAO: 12 months
Buy at Amazon ♥
Run it through our tools Clashes with my routine? Pregnancy-safe? Find a cheaper dupe Patch-test it first
Verdicts

How well it fits each concern

Verdict by concern tap a concern for the case

Promisingfor HyperpigmentationVitamin C has trial-level evidence for hyperpigmentation but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Ascorbic Acid has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Cautions: known irritants; a photosensitising active — use sun protection.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Ascorbic Acid
Standing
plausible — trials support it
Form
plausible — studied range 5–6%, from the trials on the row; needs leave-on contact; judge it after ~12 weeks
Tolerability
standard — irritant load, photosensitization
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All hyperpigmentation products →
Promisingfor Dark SpotsVitamin C has trial-level evidence for dark spots but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Ascorbic Acid has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Cautions: a photosensitising active — use sun protection.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Ascorbic Acid
Standing
plausible — trials support it
Form
plausible — studied range 1–28%, from the trials on the row; needs leave-on contact; judge it after ~12 weeks
Tolerability
standard — photosensitization
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All dark spots products →
Unprovenfor Sun DamageVitamin E has early or mechanistic evidence for sun damage — a reasonable bet, not a recommendation; the other actives here are not yet assessed for it.Limited evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Tocopheryl Acetate has early or mechanistic evidence for this concern, not trial-backed standing.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Cautions: a photosensitising active — use sun protection.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Unproven” is the verdict on 1,111 of 45,024 concern verdicts across the catalog; rule R9 decided 1,111 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9 — Plausible-tier actives alone do not earn a recommendation, and 'not for this' would overstate the case against them. 'Unproven' with the evidence dots lets the reader judge the bet (added 0.2.0 after the first shadow run put a 10% niacinamide serum at 'not for this' for hyperpigmentation). 0.5.0: the closing clause reads the other heroes — "nothing else here addresses it" only when every other active has a researched 'none' row; "not yet assessed" when that is the truth. Rows whose dots read moderate or better now reach R9p first. · the full register
Carrying active
Tocopheryl Acetate
Standing
plausible — trials support it
Form
plausible
Tolerability
standard — photosensitization
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All sun damage products →
Promisingfor MelasmaVitamin C has trial-level evidence for melasma but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Ascorbic Acid has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Cautions: known irritants; a photosensitising active — use sun protection.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Ascorbic Acid
Standing
plausible — trials support it
Form
plausible — studied range 4–5%, from the OTC monograph or label; needs leave-on contact; judge it after ~12 weeks
Tolerability
standard — irritant load, photosensitization
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All melasma products →

Also listed for Dullness — the actives here (Arbutin, Vitamin E, Vitamin C, Lactic Acid) are in our research queue for that concern; there is no verdict until their evidence rows are written. That is a gap in our table, not a mark against the product.

Where our review and the verdict differ. The review below was written on the formulation and the published trials; the verdicts above apply the stricter standing test in our methodology — an active earns a recommendation only with guideline or regulatory standing for the concern. Where the two disagree, the verdict is DermApproved’s position.

A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide

Assessment

Pros & Cons

Pros

  • ✓ 7% arbutin is one of the highest OTC concentrations available for serious brightening
  • ✓ Multi-pathway approach combining arbutin vitamin C and lactic acid targets pigmentation
  • ✓ Gentler than hydroquinone with lower risk of ochronosis and rebound pigmentation
  • ✓ Fragrance-free lightweight formula absorbs easily under moisturizer and sunscreen
  • ✓ Backed by the Nu-Derm system's decades of clinical dermatology experience
  • ✓ Effective for maintaining brightening gains between hydroquinone treatment cycles

Cons

  • ✗ Requires 3-6 months of daily use before meaningful brightening becomes visible
  • ✗ Contains SLS in a leave-on treatment cream which is unusual and potentially irritating
  • ✗ Three parabens included which will deter paraben-sensitive consumers
  • ✗ At $125 for 2 oz the price is steep for a relatively simple formulation
  • ✗ Dark spots may temporarily darken in weeks 2-8 before lightening begins
Review

Full Review

Before hydroquinone became the subject of regulatory debates and consumer anxiety, Obagi's Nu-Derm system was built around it. The original Nu-Derm Clear contained 4% hydroquinone — the gold standard for hyperpigmentation treatment — and it worked. When Obagi created the Fx line, the challenge was clear: replicate the brightening power of hydroquinone without using hydroquinone. Their answer was arbutin at 7%, and it is a compromise that mostly works but requires patience and recalibrated expectations. The pedigree behind that decision matters: Obagi Medical was founded in 1988 by dermatologist Dr. Zein Obagi, and the Nu-Derm system has spent decades being dispensed through physician offices rather than beauty counters — this is a product with a clinical lineage, sold on clinical terms.

Arbutin is hydroquinone's polite cousin. Structurally, it is a glycosylated form of hydroquinone — it converts to hydroquinone in the skin at controlled, low levels, providing tyrosinase inhibition without the concentration-dependent side effects that made prescription hydroquinone controversial. That also disposes of the dismissive framing that arbutin is merely watered-down hydroquinone: the controlled conversion is the feature, trading raw speed for a safety profile that permits long-term use without the ochronosis and rebound risks. At 7%, this is one of the highest arbutin concentrations available in an over-the-counter product, and that concentration matters. Most arbutin serums and creams hover around 1-2%; Obagi is making a serious play at this dosage.

The supporting cast is thoughtfully assembled. Ascorbic acid (vitamin C) provides a secondary brightening pathway, inhibiting melanin synthesis through a different mechanism than arbutin. Lactic acid adds gentle chemical exfoliation — promoting cell turnover to reveal fresher skin beneath existing pigmentation while also serving as a mild humectant at low concentrations. Tocopheryl acetate rounds out the antioxidant trio, protecting against the UV-induced oxidative stress that triggers melanin production in the first place.

On the skin, Clear Fx applies as a lightweight cream that blends easily and absorbs within a minute or two. There is no significant scent — the formula is not marketed as fragrance-free, but any odor is minimal and functional. The texture is unremarkable in the best sense: it does not pill, does not leave a white cast, and sits comfortably under sunscreen and makeup. For a product you need to use daily for months, this invisible wearability is essential. The protocol is simple and non-negotiable: a thin layer on clean, dry skin every evening, moisturizer over the top once it absorbs, no other exfoliating acids or benzoyl peroxide in the same routine, and broad-spectrum SPF every single morning — the lactic acid raises photosensitivity, and unprotected sun exposure will quietly undo months of pigment work. One genuinely useful trait for a brightener this serious: it is considered pregnancy-safe, which few things in the melasma-fighting arsenal are.

The results timeline is where expectations need management. Users accustomed to hydroquinone's relatively rapid visible lightening — often noticeable within two to four weeks — will find arbutin slower. Many users report that existing spots actually appear slightly darker initially as the arbutin draws pigment to the surface, a phenomenon that can last six to eight weeks. True lightening typically begins around the eight-to-twelve-week mark, and meaningful improvement in overall tone evenness may take four to six months of consistent daily use. This isn't a flaw in the product; it reflects arbutin's gentler mechanism — the temporary darkening is arguably evidence the active is working, not failing. But it does require a commitment that not every user is prepared to make. The couple hundred reviews on record reflect exactly that filter: several reviewers describe dark spots and sun damage gradually fading with less irritation than hydroquinone alternatives, while the recurring complaints are the early darkening phase, the months-long timeline, and the price.

The ingredient list is not without concerns. Sodium lauryl sulfate is present — unusual in a leave-on treatment cream and a potential irritant for sensitive skin. The formula also contains three parabens (butylparaben, methylparaben, propylparaben), which, while considered safe at cosmetic concentrations by regulatory bodies, will be a dealbreaker for consumers who prefer paraben-free products. And sodium metabisulfite, included as an antioxidant preservative, can trigger reactions in sulfite-sensitive individuals.

The price deserves honest discussion. At $125 for 2 ounces — roughly three to four months of nightly use, so call it $30-40 a month — Clear Fx is positioned at a premium that reflects the Obagi brand and physician-channel distribution. The 7% arbutin concentration partially justifies this — finding comparable arbutin concentrations elsewhere requires searching — but the base formula is otherwise straightforward. The vitamin C is listed after arbutin and surfactants, suggesting modest concentration. This isn't a sophisticated multi-pathway brightening formula; it is arbutin doing the heavy lifting with supporting actors in minor roles.

For patients coming off hydroquinone — whether by choice or because their dermatologist recommends cycling off — Clear Fx is a logical transition product. It maintains tyrosinase inhibition through a gentler mechanism, helping to preserve brightening gains without the risks associated with long-term hydroquinone use. Used as a maintenance product between hydroquinone cycles, it fills a genuine clinical gap.

As a standalone brightening treatment for someone who has never used hydroquinone, Clear Fx will work, but the timeline and price make it a commitment. The arbutin concentration is genuinely high, the formula is stable and well-preserved, and the clinical pedigree is real. Whether the $125 price tag is justified depends on how much value you place on the Obagi name and the 7% arbutin concentration — because the rest of the formula, with its SLS and parabens, does not scream premium.

Formula

Key Ingredients

The hero actives that drive this product's performance.

IngredientFunctionEvidence
Arbutin (7%) (7%) The star active in this brightening cream at one of the highest OTC concentrations available. Arbutin — a glycosylated hydroquinone derived from bearberry — competitively inhibits tyrosinase, the enzyme responsible for melanin production. At 7%, it provides substantial tyrosinase blockade without the cytotoxic risks of prescription hydroquinone, making it Obagi's chosen replacement for the original Nu-Derm Clear's 4% hydroquinone. Not yet assessed
Ascorbic Acid (Vitamin C) Provides a complementary brightening pathway to the arbutin — while arbutin blocks tyrosinase directly, vitamin C inhibits melanin oxidation and scavenges the free radicals that trigger melanogenesis. In this formula, it creates a dual-mechanism approach to pigmentation that is more effective than either ingredient alone. Limited for Hyperpigmentation
Lactic Acid An alpha hydroxy acid that serves double duty in this brightening cream — gently exfoliating melanin-laden keratinocytes from the skin's surface to reveal fresher skin beneath, while also functioning as a humectant that draws moisture into the stratum corneum. This accelerates the visible turnover of pigmented cells that the arbutin is preventing from reforming. Limited for Hyperpigmentation
Tocopheryl Acetate (Vitamin E) An antioxidant that protects against the UV-induced oxidative stress that triggers melanin production. In this formula, it supports the arbutin and vitamin C by addressing one of the upstream causes of hyperpigmentation — free radical damage — rather than just inhibiting the melanin synthesis pathway downstream. Limited for Sun Damage
Full INCI List

Water (Aqua), Arbutin, Cetyl Alcohol, Glycerin, Sodium Lauryl Sulfate, Stearyl Alcohol, Tocopheryl Acetate, Ascorbic Acid, Saponins, Sodium Metabisulfite, BHT, Lactic Acid, Disodium EDTA, Butylparaben, Methylparaben, Propylparaben.

Safety & Formulation Facts
✓ Pregnancy Safe ✓ Fragrance Free✓ Alcohol Free✓ Oil Free✓ Silicone Free✗ Paraben Free✗ Sulfate Free✗ Cruelty Free✓ Vegan✗ Fungal Acne Safe
Comedogenic Ingredients
Cetyl Alcohol
Potential Irritants
Sodium Lauryl SulfateLactic Acid
Common Allergens
Sodium Metabisulfite (sulfite sensitivity)
Compatibility

Skin Match

Best For
Works For
Not Ideal For
Routine Step

treatment

Time of Day

PM

Layering Tips

Apply a thin layer to clean, dry skin in the evening. Can be used before moisturizer. Must use broad-spectrum sunscreen during the day — the lactic acid increases photosensitivity. When used as part of the Nu-Derm Fx system, follow the system's layering protocol.

Results Timeline

No immediate visible brightening — this is a long-game product. Spots may appear slightly darker in weeks 2-8 as arbutin draws pigment to the surface. Visible lightening typically begins around 8-12 weeks. Meaningful improvement in overall tone evenness requires 4-6 months of consistent daily use.

Pairs Well With
Broad-spectrum SPF 30+ (essential)Gentle moisturizersHyaluronic acid serums
Planning a combo? Check it against what you already use
Conflicts With
Other AHA/BHA exfoliants in the same routineBenzoyl peroxide applied at the same time
See where it fits — layering order & night-splitting
Sample AM Routine
  1. Gentle cleanser
  2. Vitamin C serum
  3. Moisturizer
  4. Broad-spectrum SPF 30+
Sample PM Routine
  1. Gentle cleanser
  2. Obagi Nu-Derm Clear Fx
  3. Moisturizer
Evidence

Science & Expert Perspective

The Science

Arbutin's mechanism of action as a tyrosinase inhibitor has been extensively studied. A key study published in the Journal of Biological Chemistry (1995) demonstrated that arbutin competitively inhibits tyrosinase activity by binding to the enzyme's active site, preventing the oxidation of L-DOPA to dopachrome — a critical step in melanin synthesis. This mechanism provides dose-dependent brightening without the cytotoxic effects associated with higher hydroquinone concentrations.

One trial published in the Journal of Cosmetic Dermatology (2017) evaluated arbutin at concentrations of 1-5% and found significant reduction in melanin index after 12 weeks of daily use. The 7% concentration in this product exceeds the studied range, suggesting potentially stronger inhibition, though published data at this specific concentration is limited.

The combination of arbutin with L-ascorbic acid creates a dual-pathway approach to melanogenesis inhibition. While arbutin blocks tyrosinase directly, vitamin C intercepts reactive oxygen species that trigger melanin production and inhibits melanin oxidation — the step that darkens melanin from its lighter pheomelanin form to the darker eumelanin. A study in Pigment Cell Research (2006) established that combining multiple melanogenesis inhibitors produces additive or synergistic effects.

Lactic acid, at the AHA concentrations typical of treatment creams, accelerates keratinocyte turnover, promoting the shedding of melanin-laden surface cells. One trial published in Dermatologic Surgery (2001) documented lactic acid's dual role as both an exfoliant and a melanin-dispersing agent, supporting its inclusion in brightening formulations.

Dermatologist Perspective

Dermatology practitioners frequently recommend Clear Fx for patients transitioning off hydroquinone or those who prefer a hydroquinone-free approach to hyperpigmentation management. Dermatologists note that the 7% arbutin concentration provides meaningful tyrosinase inhibition — higher than most OTC alternatives — making it a credible tool in the brightening arsenal. However, dermatologists are clear that arbutin works on a longer timeline than hydroquinone, and managing patient expectations around the 3-6 month commitment is essential. The product is commonly prescribed as a maintenance treatment between hydroquinone cycles to prevent rebound hyperpigmentation.

Guidance

Usage & Recommendations

How to Use

Apply a thin layer to clean, dry skin every evening, focusing on areas of hyperpigmentation. Allow full absorption before applying moisturizer. Can be used as part of the full Nu-Derm Fx system or as a standalone treatment. Always use broad-spectrum SPF 30+ during the day — the lactic acid increases photosensitivity and UV exposure will counteract brightening effects. Be patient through the initial 6-8 weeks when spots may appear darker — this is temporary.

Value Assessment

At $125 for 2 oz, Clear Fx is a premium-priced brightening treatment. The 7% arbutin concentration partially justifies this — it is genuinely difficult to find comparable OTC concentrations. However, the supporting formula is simple (vitamin C, lactic acid, vitamin E), and the inclusion of SLS and parabens does not reflect the formulation sophistication expected at this price point. For budget-conscious consumers, The Ordinary's Alpha Arbutin 2% at under $10 provides arbutin at a lower but still effective concentration.

Who Should Buy

This treatment is for anyone with moderate-to-significant hyperpigmentation, sun damage, or post-inflammatory dark spots who wants a hydroquinone-free approach backed by clinical-grade formulation. Particularly well-suited for patients transitioning off hydroquinone who want to maintain their brightening progress.

Who Should Skip

Anyone expecting rapid results should look elsewhere — this is a long-commitment product. Those with sensitive or dry skin may react to the SLS. Consumers who avoid parabens should note the three paraben preservatives. Budget-conscious shoppers can find effective arbutin products at significantly lower prices from brands like The Ordinary.

Ready to try Obagi Nu-Derm Clear Fx?

Buy at Amazon ♥

Or visit the Obagi store on Amazon →

Details

Product Details

Texture

Lightweight cream that spreads easily and absorbs within a minute or two. Non-greasy, non-tacky finish that sits well under other products.

Scent

Minimal, barely perceptible scent. No added fragrance.

Packaging

Standard Obagi tube packaging in the Nu-Derm line's signature design. Tube protects the ascorbic acid from excessive air exposure.

Finish
lightweightnon-greasyinvisible
What to Expect on First Use

First applications feel unremarkable — the cream applies smoothly without tingling or irritation for most users. The lactic acid may produce very mild tingling in the first few uses. No immediate visible brightening effect. Some users notice existing dark spots appearing slightly darker in weeks 2-8 as pigment is drawn to the surface — this is expected and temporary.

How Long It Lasts

3-4 months with daily evening use

Period After Opening

12 months

Opened yours? Track the toss-by date
Best Season

All Year

Background

The Story Behind This Product

When regulatory pressure and consumer preference shifted away from hydroquinone, Obagi faced a formulation challenge: how to maintain the efficacy of their flagship Nu-Derm Clear without the ingredient that made it work. The Fx (non-hydroquinone) line was their answer, replacing 4% hydroquinone with 7% arbutin — a structural relative that provides tyrosinase inhibition through a gentler, controlled-release mechanism. The transition preserved the system's clinical positioning while acknowledging the market's move toward hydroquinone-free options.

About Obagi Legacy Brand (20+ years)

Obagi Medical was founded in 1988 by board-certified dermatologist Dr. Zein Obagi, a pioneer in skin health restoration. The Nu-Derm system is one of the brand's flagship product lines, with decades of clinical use in dermatology offices for treating hyperpigmentation and photo-aging.

Brand founded: 1988 · Product launched: 2014
Myth vs. Reality

Common Myths

Myth

Arbutin is just a weaker version of hydroquinone.

Reality

Arbutin is a glycosylated form of hydroquinone that converts to small amounts of hydroquinone in the skin. This controlled release provides tyrosinase inhibition with significantly lower risk of side effects like ochronosis or rebound hyperpigmentation. At 7%, it is a legitimate brightening active, not just a diluted alternative.

Myth

If dark spots get darker initially, the product is not working.

Reality

Temporary darkening in weeks 2-8 is a normal part of arbutin's mechanism — it draws existing melanin to the surface as it prevents new melanin formation below. This is actually a sign the product is active. Persist through this phase to see the brightening results.

FAQ

Frequently Asked Questions

How long does Obagi Nu-Derm Clear Fx take to work?

Clear Fx requires significant patience. Spots may appear slightly darker in weeks 2-8 as arbutin draws pigment to the surface. Visible lightening typically begins at the 8-12 week mark, and meaningful improvement in overall tone evenness requires 4-6 months of consistent daily use. This is slower than hydroquinone-based products but comes with fewer side effects.

Is Obagi Clear Fx the same as the original Nu-Derm Clear?

No. The original Nu-Derm Clear contained 4% hydroquinone as its active ingredient. Clear Fx replaced hydroquinone with 7% arbutin — a structurally related but gentler ingredient. Both target hyperpigmentation, but through different intensities of tyrosinase inhibition.

Can I use Obagi Clear Fx without the rest of the Nu-Derm system?

Yes, Clear Fx can be used as a standalone brightening treatment. Apply to clean skin in the evening, followed by a moisturizer. The key companion product is a broad-spectrum SPF 30+ during the day — the lactic acid in Clear Fx increases sun sensitivity, and UV exposure will counteract the brightening effects.

Does Obagi Clear Fx contain hydroquinone?

No. Clear Fx is hydroquinone-free. It uses 7% arbutin instead — a naturally derived tyrosinase inhibitor that provides brightening effects without the side-effect profile associated with prescription-strength hydroquinone.

Is Obagi Clear Fx safe during pregnancy?

The ingredients in Clear Fx — arbutin, vitamin C, lactic acid, and vitamin E — are generally considered safe during pregnancy. However, arbutin does convert to trace amounts of hydroquinone in the skin, and some dermatologists advise caution with any hydroquinone-related ingredient during pregnancy. Consult your OB-GYN before use.

Reviews

What Reviewers Tend to Say

Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.

Common Praise

Gradually and effectively lightens dark spots and sun damage

Less irritating than hydroquinone-based alternatives

Lightweight cream texture absorbs easily

Works well as part of the complete Nu-Derm Fx system

Common Complaints

Dark spots may appear darker initially before lightening begins

Requires 3-6 months of consistent use for meaningful results

Expensive at $125 for a relatively simple formulation

Contains SLS and parabens in a leave-on product

Notable Endorsements
Part of the physician-dispensed Nu-Derm Fx systemContains one of the highest OTC arbutin concentrations available
Related Conditions
hyperpigmentationdark spotssun damagemelasmadullness
Related Ingredients
arbutinvitamin clactic acidvitamin e